Adherence to disease management interventions for COPD patients: Patients' perspectives

Journal of Pharmacy Practice and Research

Volumn 36, Issue 4, 2006, Pages 278-285

  George, Johnson ^a,b   Kong, David C M ^a,c   Santamaria, Nick M ^d   Ioannides Demos, Lisa L ^a,d   Stewart, Kay ^a  

^a MONASH UNIVERSITY   (Australia)

^b ROBERT GORDON UNIVERSITY   (United Kingdom)

^c The Alfred   (Australia)

^d Ambulatory and Community Services

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIBIOTIC AGENT; OXYGEN; PREDNISOLONE; SALBUTAMOL;

ADULT; AGED; ATTITUDE TO HEALTH; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CLINICAL ARTICLE; CLINICAL TRIAL; COMMUNITY CARE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST; DEMOGRAPHY; DISEASE SEVERITY; DRUG DOSAGE FORM; EMPATHY; FEMALE; HEALTH BELIEF; HEALTH PRACTITIONER; HUMAN; INTERVIEW; MALE; MEDICAL DECISION MAKING; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT SATISFACTION; PROGNOSIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REVIEW; SYMPTOMATOLOGY;

EID: 33846528547     PISSN: 1445937X     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.2055-2335.2006.tb00630.x     Document Type: Review

References (63)

1. World Health Organization. World health report. Geneva: WHO; 2004.
2. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997; 349: 1498-504.
3. Australian Institute of Health and Welfare. Australia's Health 2002. Canberra: AIHW 2002; 493.
4. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163: 1256-76.
5. Haynes RB, Taylor DW, Sackett DL. Compliance in healthcare. Baltimore: John Hopkins University Press; 1979.
6. Marinker M, Blenkinsopp A, Bond C, et al. From compliance to concordance: achieving shared goals in medicine taking. London: Royal Pharmaceutical Society of Great Britain; 1997.
7. Stanton LA, Peterson GM, Rumble RH, Cooper GM, Polack AE. Drug-related admissions to an Australian hospital. J Clin Pharm Ther 1994; 19: 341-7.
8. Sackett DL, Snow JC. The magnitude of compliance and non-compliance. In: Haynes RB, Taylor DW, Sackett DL, editors. Compliance in healthcare. Baltimore: John Hopkins University Press; 1979. p. 11-22.
9. Fuso L, Incalzi RA, Pistelli R, Muzzolon R, Valnete S, Pagliari G, et al. Predicting mortality of patients hospitalized for acutely exacerbated chronic obstructive pulmonary disease. Am J Med 1995; 98: 272-7.
10. Garcia-Aymerich J, Barreiro E, Farrero E, Marrades RM, Morera J, Anto JM. Patients hospitalized for COPD have a high prevalence of modifiable risk factors for exacerbation (EFRAM study). Eur Respir J 2000; 16: 1037-42.
11. DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care 2002; 40: 794-811.
12. James PN, Anderson JB, Prior JG, White JP, Henry JA, Cochrane GM. Patterns of drug taking in patients with chronic airflow obstruction. Postgrad Med J 1985; 61: 7-10.
13. Dolce JJ, Crisp C, Manzella B, Richards JM, Hardin JM, Bailey WC. Medication adherence patterns in chronic obstructive pulmonary disease. Chest 1991; 99: 837-41.
14. Gallefoss F, Bakke PS, Rsgaard PK. Quality of life assessment after patient education in a randomized controlled study on asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 159: 812-7.
15. Turner J, Wright E, Mendella L, Anthonisen N. Predictors of patient adherence to long-term home nebulizer therapy for COPD. Chest 1995; 108: 394-400.
16. Hatton MQ, Allen MB, Vathenen SV, Feely MP, Cooke NJ. Compliance with oral corticosteroids during steroid trials in chronic airways obstruction. Thorax 1996; 51: 323-4.
17. Pepin JL, Barjhoux CE, Deschaux C, Brambilla C. Long-term oxygen therapy at home. Compliance with medical prescription and effective use of therapy. Chest 1996; 109: 1144-50.
18. van Grunsven PM, van Schayck CP, van Deuveren M, van Herwaaden CL, Akkermans RP, van Weel C. Compliance during long-term treatment with fluticasone propionate in subjects with early signs of asthma or chronic obstructive pulmonary disease (COPD): results of the Detection, Intervention, and Monitoring Program of COPD and Asthma Study. J Asthma 2000; 37: 225-34.
19. Rand CS, Nides M, Cowles MK, Wise RA, Connett J. Long-term metered-dose inhaler adherence in a clinical trial. Am J Respir Crit Care Med 1995; 152: 580-8.
20. Bosley CM, Corden ZM, Rees PJ, Cochrane GM. Psychological factors associated with use of home nebulized therapy for COPD. Eur Respir J 1996; 9: 2346-50.
21. Chryssidis E, Frewin DB, Frith PA, Dawes ER. Compliance with aerosol therapy in chronic obstructive lung disease. N Z Med J 1981; 94: 375-7.
22. Dompeling E, van Grunsven PM, van Schayck CP, Folgering H, Molema J, van Weel C. Treatment with inhaled steroids in asthma and chronic bronchitis: long-term compliance and inhaler technique. Fam Pract 1992; 9: 161-6.
23. Young P, Dewse M, Fergusson W, Kolbe L. Respiratory rehabilitation in chronic obstructive pulmonary disease: predictors of nonadherence. Eur Respir J 1999; 13: 855-9.
24. Mapel DW, Picchi MA, Hurley JS, Frist FJ, Petersen HV, Mapel VM, et al. Utilization in COPD: patient characteristics and diagnostic evaluation. Chest 2000; 117: 346S-353S.
25. Emery CF, Shermer RL, Hauck ER, Hsiao ET, MacIntyre NR. Cognitive and psychological outcomes of exercise in a 1-year follow-up study of patients with chronic obstructive pulmonary disease. Health Psychol 2003; 22: 598-604.
26. Nichol KL, Baken L, Nelson A. Relation between influenza vaccination and outpatient visits, hospitalization, and mortality in elderly persons with chronic lung disease. Ann Intern Med 1999; 130: 397-403.
27. Burke LE, Dunbar-Jacob J. Adherence to medication, diet, and activity recommendations: from assessment to maintenance. J Cardiovasc Nurs 1995; 9: 62-79.
28. Fraser D. QSR NVivo reference guide. 2nd ed. Melbourne: Qualitative Solutions and Research; 1999.
29. Chryssidis E, Frewin DB, Frith PA, Dawes ER. Compliance with aerosol therapy in chronic obstructive lung disease. N Z Med J 1981; 94: 375-7.
30. Connolly MJ. Inhaler technique of elderly patients: comparison of metered-dose inhalers and large volume spacer devices. Age Ageing 1995; 24: 190-2.
31. Smith F. Health services research methods in pharmacy: qualitative interviews. Int J Pharm Prac 1998; 6: 97-108.
32. Rosenstock I. The health belief model and preventative health behaviour. Health Educ Monogr 1974; 354-86.
33. Rotter J. Generalized expectancies for internal versus external control of reinforcements. Psychol Mon 1966; 80: 609.
34. Leventhal H, Diefenbach M, Leventhal EA. Illness cognition: using common sense to understand treatment adherence and affect cognition interactions. Cognit Ther Res 1992; 16: 143-63.
35. Morris LS, Schulz RM. Medication compliance: the patient's perspective. Clin Ther 1993; 15: 593-606.
36. Buston KM, Wood SF. Non-compliance amongst adolescents with asthma: listening to what they tell us about self-management. Fam Pract 2000; 17: 134-8.
37. Green J, Britten N. Qualitative research and evidence based medicine. BMJ 1998; 316: 1230-2.
38. Minichiello V, Aroni R, Timewell E, et al. In-depth interviewing: principles, techniques, analysis. Melbourne: Longman; 1990.
39. Incalzi RA, Pedone C, Onder G, Pahor M, Carbonin PU. Predicting length of stay of older patients with exacerbated chronic obstructive pulmonary disease. Aging (Milano) 2001; 13: 49-57.
40. Earnest MA. Explaining adherence to supplemental oxygen therapy: the patient's perspective. J Gen Intern Med 2002; 17: 749-55.
41. Benson J, Britten N. Patients' decisions about whether or not to take antihypertensive drugs: qualitative study. BMJ 2002; 325: 873.
42. Remien RH, Hirky AE, Johnson MO, Weinhardt LS, Whittier D, Le GM. Adherence to medication treatment: a qualitative study of facilitators and barriers among a diverse sample of HIV+ men and women in four US cities. AIDS Behav 2003; 7: 61-72.
43. Britten N. Patients' ideas about medicines: a qualitative study in a general practice population. Br J Gen Pract 1994; 44: 465-8.
44. Townsend A, Hunt K, Wyke S. Managing multiple morbidity in mid-life: a qualitative study of attitudes to drug use. BMJ 2003; 327: 837.
45. Stromberg A, Brostrom A, Dahlstrom U, Fridlund B. Factors influencing patient compliance with therapeutic regimens in chronic heart failure: a critical incident technique analysis. Heart Lung 1999; 28: 334-41.
46. Woller W, Kruse J, Winter P, Mans EJ, Alberti L. Cortisone image and emotional support by key figures in patients with bronchial asthma. An empirical study. Psychother Psychosom 1993; 59: 190-6.
47. Boulet LP. Perception of the role and potential side effects of inhaled corticosteroids among asthmatic patients. Chest 1998; 113: 587-92.
48. Dowell J, Hudson H. A qualitative study of medication-taking behaviour in primary care. Fam Pract 1997; 14: 369-75.
49. Rose LE, Kim MT, Dennison CR, Hill MN. The contexts of adherence for African Americans with high blood pressure. J Adv Nurs 2000; 32: 587-94.
50. van Es SM, Kaptein AA, Bezemer PD, Nagelkerke AF, Colland VT, Bouter LM. Predicting adherence to prophylactic medication in adolescents with asthma: an application of the ASE-Model. Patient Educ Couns 2002; 47: 165-71.
51. Apter AJ, Reisine ST, Affleck G, Barrows E, ZuWallack RL. Adherence with twice-daily dosing of inhaled steroids. Socioeconomic and health-belief differences. Am J Respir Crit Care Med 1998; 157: 1810-17.
52. Dowson CA, Town GI, Frampton C, Mulder RT. Psychopathology and illness beliefs influence COPD self-management. J Psychosom Res 2004; 56: 333-40.
53. Haynes RB. Determinants of compliance: the disease and the mechanics of treatment. In: Haynes RB, Taylor DW, Sackett DL, editors. Compliance in healthcare. Baltimore: John Hopkins University Press; 1979. p. 49-62.
54. Cramer JA, Scheyer RD, Mattson RH. Compliance declines between clinic visits. Arch Intern Med 1990; 150: 1509-10.
55. Clay DL. Commentary: rethinking our interventions in pédiatrie chronic pain and treatment research. J Pediatr Psychol 2000; 25: 53-5.
56. Ryan GW, Wagner GJ. Pill taking 'routinization': a critical factor to understanding episodic medication adherence. AIDS Care 2003; 15: 795-806.
57. Cordina M, McElnay JC, Hughes CM. Assessment of a community pharmacy-based program for patients with asthma. Pharmacotherapy 2001; 21: 1196-203.
58. De Blaquiere P, Christensen DB, Carter WB, Martin TR. Use and misuse of metered-dose inhalers by patients with chronic lung disease. A controlled, randomized trial of two instruction methods. Am Rev Respir Dis 1989; 140: 910-16.
59. Simmons MS, Nides MA, Rand CS, Wise RA, Tashkin DP. Trends in compliance with bronchodilator inhaler use between follow-up visits in a clinical trial. Chest 1996; 109: 963-8.
60. DiMatteo MR, Sherbourne CD, Hays RD, Ordway L, Kravitz RL, McGlynn EA, et al. Physicians' characteristics influence patients' adherence to medical treatment: results from the Medical Outcomes Study. Health Psychol 1993; 12: 93-102.
61. Vermeire E, Hearnshaw H, van Royen P, Denekens J. Patient adherence to treatment: three decades of research. J Clin Pharm Ther 2001; 26: 331-42.
62. Nagy VT, Wolfe GR. Cognitive predictors of compliance in chronic disease patients. Med Care 1984; 22: 912-21.
63. Tillotson LM, Smith MS. Locus of control, social support, and adherence to the diabetes regimen. Diabetes Educ 1996; 22: 133-9.